Rep. Lisa C. McClain Purchases Shares of Revvity Inc. (NYSE:RVTY)

Key Points

• Representative Lisa C. McClain recently acquired shares of Revvity Inc. (NYSE:RVTY) for an investment between $1,001 and $15,000, disclosed in a filing on August 13th.
• Revvity reported quarterly earnings of $1.18 per share, exceeding estimates by $0.04, with a revenue of $720.28 million, reflecting a year-over-year increase of 4.1%.
• The company declared a $0.07 quarterly dividend, with an annualized yield of 0.3%, scheduled for payment on November 7th to investors of record by October 17th.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Revvity Inc. NYSE: RVTY. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Revvity Trading Down 0.9%

Revvity stock traded down $0.79 during midday trading on Tuesday, reaching $91.35. The stock had a trading volume of 2,115,552 shares, compared to its average volume of 1,186,052. The stock's 50-day simple moving average is $94.43 and its 200 day simple moving average is $98.51. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. Revvity Inc. has a twelve month low of $85.12 and a twelve month high of $129.50. The stock has a market capitalization of $10.60 billion, a PE ratio of 38.71, a price-to-earnings-growth ratio of 2.47 and a beta of 0.91.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The company had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same period last year, the company posted $1.22 earnings per share. The firm's revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be issued a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is presently 11.86%.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC purchased a new position in shares of Revvity during the 2nd quarter valued at $32,000. Optiver Holding B.V. acquired a new position in Revvity during the 4th quarter worth $33,000. Quarry LP lifted its position in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after acquiring an additional 95 shares during the last quarter. MUFG Securities EMEA plc acquired a new position in shares of Revvity during the second quarter valued at about $34,000. Finally, UMB Bank n.a. raised its position in shares of Revvity by 138.8% during the second quarter. UMB Bank n.a. now owns 406 shares of the company's stock valued at $39,000 after buying an additional 236 shares during the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Bank of America cut their price objective on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. The Goldman Sachs Group decreased their price target on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. decreased their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Raymond James Financial restated an "outperform" rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Finally, UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and reduced their price objective for the stock from $145.00 to $115.00 in a research report on Thursday, May 1st. Ten analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $120.07.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.